Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
You asked, we listened: New resource for people with HIV on Medicare-Medicaid dual eligibility now available.News Article updated on 01/22/2024
-
Kern County Rapid ART
Kern County Rapid ART links people with a new diagnosis of HIV to ART. The Kern County Health Officer’s Clinic identifies people with a new diagnosis of HIV through onsite testing, surveillance data, and referrals from local hospital emergency departments. Kern County Rapid ART provides support services and refers clients to other community clinics for ongoing care. A study of clients with a new diagnosis of HIV in 2021 found that on average, Kern County Rapid ART clients were linked to care and provided ART within two days of diagnosis.Resource from the RWHAP Best Practices Compilation updated on 01/24/2024
-
American Rescue Plan Subsidies Make Marketplace and COBRA Insurance More Affordable
The American Rescue Plan includes new premium subsidies to help people afford their Marketplace and COBRA health insurance plans.Blog updated 03/21/2023
-
Tech/Mobile Apps Supporting HIV Care
Technology-focused tools to support HIV care engagement.Blog updated 04/10/2023
-
New Health Coverage Opportunities and Resources through the American Rescue Plan Act
The American Rescue Plan Act includes expanded eligibility for both Marketplace and COBRA subsidies and more. Also, the 2019 Public Charge rule will no longer be enforced.Blog updated 12/15/2021
-
NIH Center Efforts Towards the EHE Initiative: Innovative Partnerships to Implement New Tools
Implementation of innovations for End the HIV Epidemic (EHE) efforts requires innovative research/community collaborations. This session presents LA County’s efforts to prepare for long-acting injectable treatment, Miami’s pilot of telemedicine for test-and-treat at a syringe services program, and Philadelphia’s partnership to evaluate a U=U campaign.
Resource (Conference Presentation) updated 09/14/2023
-
Updates from Recent HIV Research Conferences: CROI 2020 and AIDS 2020
Review of research insights from two major HIV conferences held in 2020.Resource (Conference Presentation) updated 09/14/2023
-
New and Investigational ART Drugs and Strategies
Review of antiretroviral regimens in the clinical trials phase.Resource (Conference Presentation) updated 09/14/2023
-
Treating HIV in 2020: Interactive Cases From the Clinic(ians) and Panel Discussion
Case examples of starting antiretroviral therapy in patients under varied scenarios.Resource (Conference Presentation) updated 09/14/2023
-
Rapid ART Dissemination Assistance Provider
Project to facilitate the implementation of Rapid ART initiation in RWHAP provider settings by compiling and disseminating implementation resources nationwide. Project period: 2020-2023.RWHAP Technical Assistance Provider updated on 03/04/2024
-
AIDS at 40: Envisioning a Future We Never Imagined
June 5, 1981. Many people who work in the HIV field know its significance: the day when the first AIDS cases were officially reported.Blog updated 06/10/2021
-
Eligibility for Simplification of HIV Salvage Regimens Based on Genotypic
Resource (Conference Presentation) updated 09/14/2023
-
Adolescent Viral Load Suppression: Challenges and Success Stories
Resource (Conference Presentation) updated 09/14/2023
-
Average Time to Initiation of Antiretroviral Therapy - Newly Diagnosed HIV Patients - University of Utah
Resource (Conference Presentation) updated 09/14/2023
-
Rapid Access of Initial HIV Appointment and ART Prescription
Resource (Conference Presentation) updated 09/14/2023
-
New Investigational ART Drugs and Strategies
Review of investigational drugs in phase III trials (as of 2021: Islatravir, Lenacapravir, GSK 3640254/aka GSK “254) and how these investigational agents might be used in treatment in the future. Also, review of long-acting injectables.Resource (Conference Presentation) updated 09/14/2023
-
Managing Polypharmacy and Drug-Drug Interactions
Review of common mechanisms for drug interactions with contemporary ART; therapeutic classes of drugs with high interaction potential with ART; distinctions between oral vs intramuscular cabotegravir/rilpivirin interactions; and comparison of the clinical pharmacology and drug interaction potential of tenofovir alafenamide vs tenofovir disoproxilfumarate.Resource (Conference Presentation) updated 09/14/2023
-
Expanded Access to Subsidized Marketplace Insurance Plans
Did you know? Most people with very low incomes can now enroll in subsidized Marketplace coverage.Blog updated 04/14/2022
-
Transgender Women Engagement and Entry to Care (T.W.E.E.T): E2i
T.W.E.E.T. aims to engage transgender women in HIV care by combining weekly peer-based education and discussion groups, leadership training, community building, and the provision of supportive services. Three sites implemented T.W.E.E.T. as part of E2i, an initiative funded by the RWHAP Part F SPNS program from 2017–2021. Clients had improved outcomes across the HIV care continuum 12 months after enrollment in T.W.E.E.T.Resource from the RWHAP Best Practices Compilation updated on 02/09/2024
-
Long-Acting Injectable ART: Coverage and Cost-Sharing Considerations
Review of fact sheet on different coverage and cost-sharing considerations for LAI ART across public and private payers.Blog updated 12/22/2022